Kiromic BioPharma Inc.
5 clinical trials · Sponsor
◉ Watch Kiromic BioPharma Inc.
| Record | Firm | Date |
|---|---|---|
| Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases (NCT06069570) | Kiromic BioPharma Inc. | 2023-11-07 |
Track Kiromic BioPharma Inc. automatically
Every clearance here is in the API, with alerts when new ones post.